Evidence map›Paper›PMID 30354262›Full record

ReviewArteriosclerosis, thrombosis, and vascular biology2018

Vascular Smooth Muscle Remodeling in Conductive and Resistance Arteries in Hypertension.

Isola A M Brown, Lukas Diederich, Miranda E Good, Leon J DeLalio, Sara A Murphy, Miriam M Cortese-Krott, Jennifer L Hall, Thu H Le, Brant E Isakson

Abstract readReview
In one paragraph

Review in Arteriosclerosis, thrombosis, and vascular biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 147 papers.

0numbers the graph read from it
0cells of the map it votes in
147citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

147 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. METTL3 mediates mJournal of advanced research · 2026
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

87 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Isola A M BrownFrom the Robert M. Berne Cardiovascular Research Center (I.A.M.B., M.E.G., L.J.D., S.A.M., B.E.I.).
Lukas DiederichCardiovascular Research Laboratory, Division of Cardiology, Pneumology and Angiology, Medical Faculty, Heinrich Heine University, Dusseldorf, Germany (L.D., M.M.C.-K.).
Miranda E GoodFrom the Robert M. Berne Cardiovascular Research Center (I.A.M.B., M.E.G., L.J.D., S.A.M., B.E.I.).
Leon J DeLalioFrom the Robert M. Berne Cardiovascular Research Center (I.A.M.B., M.E.G., L.J.D., S.A.M., B.E.I.).
Sara A MurphyFrom the Robert M. Berne Cardiovascular Research Center (I.A.M.B., M.E.G., L.J.D., S.A.M., B.E.I.).
Miriam M Cortese-KrottCardiovascular Research Laboratory, Division of Cardiology, Pneumology and Angiology, Medical Faculty, Heinrich Heine University, Dusseldorf, Germany (L.D., M.M.C.-K.).
Jennifer L HallLillehei Heart Institute (J.L.H.).
Thu H LeDivision of Nephrology, Department of Medicine (T.H.L.).
Brant E IsaksonFrom the Robert M. Berne Cardiovascular Research Center (I.A.M.B., M.E.G., L.J.D., S.A.M., B.E.I.).

Funding

Role of Pannexins in Vascular Smooth Muscle CellsP01HL120840 · NHLBI · UNIVERSITY OF VIRGINIA · PI BAYLISS, DOUGLAS A., RAVICHANDRAN, KODI S · 2014 to 2023
$24.0M
BASIC CARDIOVASCULAR RESEARCH TRAINING GRANTT32HL007284 · NHLBI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Brant E Isakson, Gary K Owens · 1985 to 2026
$19.6M
Mechanisms of Heterocellular Signaling at the Myoenothelial JunctionR01HL088554 · NHLBI · UNIVERSITY OF VIRGINIA · PI ISAKSON, BRANT E, WEISS, MITCHELL J · 2008 to 2017
$3.8M
Renal Mechanisms of Blood Pressure Regulation and Salt Sensitivity by CollectrinR01DK113632 · NIDDK · UNIVERSITY OF VIRGINIA · PI LE, THU H. · 2017 to 2021
$1.8M
NHLBI NIH HHS P01 HL120840NHLBI NIH HHS R01 HL088554NHLBI NIH HHS T32 HL007284NIDDK NIH HHS R01 DK113632
6 · The paper itself

Abstract

Cardiovascular disease is a leading cause of death worldwide and accounts for >17.3 million deaths per year, with an estimated increase in incidence to 23.6 million by 2030.

Indexed as

Vascular RemodelingAnimalsAntihypertensive AgentsArteriesCardiovascular DiseasesHumansHypertensionInflammationMuscle, Smooth, VascularMyocytes, Smooth MuscleRisk FactorsSignal TransductionSynaptic TransmissionVascular ResistanceAntihypertensive Agentshypertensionmyocardial infarctionsmooth musclevascular remodeling

Identifiers

PMID30354262
PMCPMC6205219

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.